Logo
Login
$CMPX
$0.75 -$0.01 (1.81%) Close

Company Executives

$CMPX Management Team

Dr. Carl Gordon

Independent Chairman of the Board

Age 60
Compensation $110.7K USD
Sex Male

Dr. Thomas Schuetz

Chief Executive Officer

Vice Chairman of the Board

Age 64
Compensation $3.093M USD
Sex Male

Mr. Barry Shin

Chief Financial Officer

Age 53
Compensation $1.221M USD
Sex Male

Mr. Neil Lerner

Senior Vice President

Chief Accounting Officer and Principal Accounting Officer

Age 57
Compensation -
Sex Male

Mr. Jonathan Anderman

Senior Vice President

General Counsel

Corporate Secretary

Age 42
Compensation $893.6K USD
Sex Male

Board of Directors

From the proxy statement filed Apr 29, 2026
Directors
7
serving now
Independent
Not stated
the proxy does not say
Average tenure
6.9 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Thomas J. Schuetz
CEO
 65 2015
11 years
 Not stated None stated None stated Paid as CEO
Richard S. Lindahl
62 2023
3 years
 Not stated None stated None stated $163,400
Ellen Chiniara
67 2022
4 years
 Not stated None stated None stated $168,400
Mary Ann Gray
73 2022
4 years
 Not stated None stated BioAtla, Inc., Keros Therapeutics, Inc. $153,400
Philip J. Ferneau
64 2015
11 years
 Not stated None stated None stated $163,400
James P. Boylan
59 2022
4 years
 Not stated None stated Immunome, Inc., Zenas BioPharma, Inc. $158,400
Carl L. Gordon
61 2015
11 years
 Not stated None stated Keros Therapeutics Inc., Lomond Therapeutics Holdings, Inc. $173,400

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans